NCT05712356Phase 2Completed

A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors

Study sponsor: Lisata Therapeutics, Inc. · LSTA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-04-05Actual
Enrollment · participants66Actual
Source updated2026-09-28Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Terminated. After: Completed.

Check registry source

· 5 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Incidence of adverse events. After: Measure: Number of Subjects Experiencing Any Adverse Event.

Actual enrollment decreased by 1 participants

Before: 67 participants (actual). After: 66 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 18 Apr 2026. After: 5 Apr 2026.

Recruitment status changed

Before: Active not recruiting. After: Terminated.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview